Scale Investment in Paloma

You may also like

12 August 2020

Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia

08 October 2012

Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

14 October 2021

Blade Therapeutics Announces FDA Orphan Drug Designation Granted to Cudetaxestat for Treatment of Systemic Sclerosis

12 December 2013

Hatchtech receives FDA special protocol agreement of DeOvo™ phase III studies and strengthens patent portfolio

27 May 2017

OneVentures makes first investment for the Biomedical Translation Fund

10 March 2016

Thinking beyond the ideas boom: What Australia really needs is later stage capital and experience

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor
clear Close